These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 3544378

  • 1. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
    Kupin WL, Venkat KK, Norris C, Florence-Green D, Dienst S, Oh HK, Feldkamp C, Levin NW.
    Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
    [Abstract] [Full Text] [Related]

  • 2. Low-dose cyclosporine for cadaveric renal transplantation.
    Vanderwerf BA, Serota AI.
    Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
    [Abstract] [Full Text] [Related]

  • 3. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
    Rocher LL, Hodgson RJ, Merion RM, Swartz RD, Keavey S, Turcotte JG, Campbell DA.
    Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
    [Abstract] [Full Text] [Related]

  • 4. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
    Kupin W, Venkat KK, Oh HK, Dienst S.
    Transplantation; 1988 Jan; 45(1):53-5. PubMed ID: 3276062
    [Abstract] [Full Text] [Related]

  • 5. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 6. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
    Sutherland DE, Fryd DS, Strand MH, Canafax DM, Ascher NL, Payne WD, Simmons RL, Najarian JS.
    Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
    Griño JM, Alsina J, Sabater R, Castelao AM, Gil-Vernet S, Andres E, Sabate I, Mestre M, Seron D, Diaz C.
    Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
    [Abstract] [Full Text] [Related]

  • 9. Cyclosporine in renal transplantation: a single institutional experience.
    Ferguson RM, Sommer BG.
    Am J Kidney Dis; 1985 Jun; 5(6):296-306. PubMed ID: 3925761
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine versus azathioprine: a review of 200 consecutive cadaver renal transplant recipients.
    Kropp KA, Wolfe C, Jhunjhunwala JS, Selman SH.
    J Urol; 1989 Jul; 142(1):28-31. PubMed ID: 2659825
    [Abstract] [Full Text] [Related]

  • 11. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.
    Klintmalm G, Säwe J, Ringdén O, von Bahr C, Magnusson A.
    Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851
    [Abstract] [Full Text] [Related]

  • 12. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
    Shabtai M, Ben-Haim M, Zemer D, Malinger-Saavedra P, Rosin D, Kuriansky J, Lustig S, Shabtai EL, Shapira Z, Ayalon A.
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
    [Abstract] [Full Text] [Related]

  • 13. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP, Simmons RL, Sutherland DE, Canafax DM, Ascher NL, Payne WD, Flick B, Najarian JS, Fryd DS.
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [Abstract] [Full Text] [Related]

  • 14. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
    Kupin WL, Venkatachalam KK, Oh HK, Dienst S, Levin NW.
    Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
    [Abstract] [Full Text] [Related]

  • 15. A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation.
    Lindholm A, Dahlqvist R, Groth GG, Sjöqvist F.
    Br J Clin Pharmacol; 1990 Sep; 30(3):443-52. PubMed ID: 2223423
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine: five years' experience in cadaveric renal transplantation.
    Merion RM, White DJ, Thiru S, Evans DB, Calne RY.
    N Engl J Med; 1984 Jan 19; 310(3):148-54. PubMed ID: 6361559
    [Abstract] [Full Text] [Related]

  • 18. Effect of renal allograft dysfunction upon cyclosporine trough levels in host blood.
    Arnold AN, Waltzer WC, Anaise D, Weinstein SW, Rapaport FT.
    Transplantation; 1985 Dec 19; 40(6):605-10. PubMed ID: 3907030
    [Abstract] [Full Text] [Related]

  • 19. Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.
    Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP, Sirolimus Renal Function Study Group.
    Transplantation; 2002 Dec 15; 74(11):1560-7. PubMed ID: 12490789
    [Abstract] [Full Text] [Related]

  • 20. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.
    Transpl Immunol; 2008 Nov 15; 20(1-2):32-42. PubMed ID: 18773960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.